HNO Praxis Dreieich
- Address
- Heckenweg 3, 63303 Dreieich, Germany
HNO Praxis Dreieich - Allergic Rhinitis & Immunotherapy Research Center
HNO Praxis Dreieich is a specialized otolaryngology practice dedicated to advancing the understanding and treatment of allergic respiratory conditions. The center demonstrates significant expertise in conducting clinical trials focused on allergen-specific immunotherapy and allergic rhinoconjunctivitis management, with particular emphasis on pediatric and adult populations.
- Birch pollen-induced allergic rhinitis and rhinoconjunctivitis research across multiple age groups
- Subcutaneous immunotherapy (SCIT) trials evaluating novel allergoid formulations
- House dust mite (HDM) allergy treatment studies in patients with moderate to severe symptoms
- Sublingual immunotherapy (SLIT) efficacy and safety assessments in children and adolescents
The center's research portfolio reflects a comprehensive approach to allergen immunotherapy development, including both subcutaneous and sublingual administration routes. Their involvement in Phase IIIb multicenter trials demonstrates capacity for rigorous placebo-controlled studies evaluating seasonal and perennial allergen immunotherapy, with expertise in measuring combined symptom and medication scores as primary efficacy endpoints.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 49 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 49 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Inmunotek S.L.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in HNO Praxis Dreieich
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Mannan-Conjugated Betula Pendula Pollen Allergoid in Birch Pollen-Induced Allergic Rhinitis | CCDRD Cooperative Clinical Drug Research and Development AG, ClinCompetence Cologne GmbH, Inmunotek S.L. | Phase III | Not Recruiting | Feb 2024 | Jun 2024 |
IMP list
lock Showing 1 of 49 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cat Epithelia | 3 | Unknown | 2024-08-22 | 2026-06-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
